A Retrospective Study of Covid-19 Disease in Confirmed Tuberculosis Patients from a Tertiary Care Centre in Ahmedabad

Alpesh V  Patel; Kinnari K  Rathod; Nehal R  Patel; Rachana M  Khokhani; Happy A Patel; Neel R  Patel

doi:10.5455/njcm.20201006052006

Authors

Alpesh V Patel Department of ENT, Smt. N.H.L Municipal Medical College, Ahmedabad
Kinnari K Rathod Department of ENT, Smt. N.H.L Municipal Medical College, Ahmedabad
Nehal R Patel Department of ENT, Smt. N.H.L Municipal Medical College, Ahmedabad
Rachana M Khokhani Department of ENT, Smt. N.H.L Municipal Medical College, Ahmedabad
Happy A Patel Department of ENT, Smt. N.H.L Municipal Medical College, Ahmedabad
Neel R Patel Department of ENT, Smt. N.H.L Municipal Medical College, Ahmedabad

DOI:

https://doi.org/10.5455/njcm.20201006052006

Keywords:

Covid -19, Tuberculosis, Co-Infection

Abstract

Background: Tuberculosis (TB) is long standing disease and SARS-COV-2 being global pandemic in current era. Interactions between SARS-COV-2 and TB needs analysis, as both has major infection-related morbidity and mortality worldwide. This study was conducted to evaluate impact of super imposing viral pandemic over chronic diseases like tuberculosis.

Methodology: A Retrospective study done in 75 patients registered under RNTCP program at our centre. Epidemiological data, diagnostic timing of TB, duration of AKT, history of SARS-COV-2 symptoms and SARS-COV-2 diagnostic result were evaluated. Analysis conducted based on incidence of COVID-19 infection in active cases of TB.

Results: Male: Female ratio was 1.88:1 with majority belongs to age group of 35 to 55years. Only 3 patients developed influenza like symptoms who tested negative for SARS-COV-2. None COVID-19 suspected or positive patient were reported amongst laboratory confirmed TB patients taking AKT, indicating TB drugs definitely have some impact on SARS-COV-2 virus.

Conclusion: TB and COVID-19 co-infection has limited cases. Very few individuals who were exposed to SARS-COV-2 during AKT treatment developed influenza like symptoms, however tested negative for SARS-COV-2. A larger study is needed to understand any role played by TB infection or AKT drugs on covid-19 disease.

References

Chopra, K K et al. “COVID 19 and tuberculosis.” The Indian journal of tuberculosis 2 (2020): vol. 67, 149-151. doi:10.1016/j.ijtb.2020.06.001

COVID-19 and TB: frequently asked questions. Available at https ://www.theun ion.org/news-centr e/covid -19/covid -tb-faqs, Version 2, Accessed April 22, 2020.

Tadolini M, Codecasa LR, García-García Jé-Mía, et al. Active tuberculosis: sequelae and COVID-19 co-infection: first co-hort of 49 cases. Eur Respir J 2020(in press)

MoHFW COVID-19 India dashboard updates. Available at https://www.mohfw.gov.in Accessed on October 5,2020.

Togun, T., Kampmann, B., Stoker, N.G. et al. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob 19, 21 (2020). https://doi.org/10.1186/s12941-020-00363-1.

Radu C, Cristina G, Cristina P, Bogdan A, Iolanda P, Andrei C, Alexandru B et al Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes doi: https://doi.org/10.1101/2020.04.28.20082917 medRxiv 2020.04.28.20082917

Wingfield T, Cuevas LE, MacPherson P, Millington KA, Squire SB. Tackling two pandemics: a plea on World Tuber-culosis Day. Lancet Respir Med.2020, 537-538. https ://doi.org/10.1016/S2213 -2600(20)30151 -X.

ICMR Information on coronavirus (COVID-19) https:// www.icmr.gov.in Accessed on 29th september 2020

Martinez-Alvarez M, Jarde A, Usuf E, Brotherton H, Bittaye M, Samateh AL Antonio M, Vives-Tomas J, D’Alessandro U, Roca A. COVID-19 pandemic in west Africa. Lancet Glob Health. 2020, e631-633. https://doi.org/10.1016/S2214-109X(20)30123 -6.

Coronavirus Outbreak. Available at: https://www. worldometers.info/coronavirus/. Accessed 22 septem-ber 2020

Singh A, Gupta A, Das K. Severe Acute Respiratory Syn-drome Coronavirus-2 and Pulmonary Tuberculosis Coinfec-tion: Double Trouble. DOI: 10.21203/rs.3.rs-22464/v1. https://www.researchsquare.com/article/rs-22464/v1.

World Health Organization. Global tuberculosis report 2019. Geneva: WHO; 2019 (WHO/CDS/TB/2019.15). Avail-able from: https://www.who.int/tb/publications/ glob-al_report/en/

Chen Y, Wang Y, Fleming J, et. al. Active or latent tubercu-losis increases susceptibility to COVID-19 and disease se-verity. MedRxiv preprint 2020. doi: https://doi.org/ 10.1101/2020.03.10.20033795

Xing Q, Li G, Xing Y, et. al. Precautions are needed for COVID-19 patients with Coinfection of Common Respirato-ry Pathogens. MedRxiv 2020.02.29.20027698; doi:https://doi.org/10.1101/2020.02.29.20027698